Qrons Inc. (QRON)
Qrons Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Glendale, BY, US. The stock last traded at $0.01, down 0.89% on the session, giving a market capitalisation of $199,800. On trailing twelve-month figures it carries a trailing P/E of -2.77, a net margin of 0.0%. Its beta of 0.86 implies it has historically moved less than the broad market.
Qrons, Inc. is a biotechnology company, which engages in the development of treatments and technologies for neuronal and infectious diseases. Its proprietary patents include Techniques for Promoting Neuronal Recovery, Therapeutic Polypseudorotaxane Hydrogels, and Tellurium Compositions and Techniques for Use Therewith. The company was founded by Jonah Martin Meer and Ido Merfeld on August 22, 2016 and is headquartered in Glendale, CA.
Qrons Inc. is most often compared with the following Healthcare names: